Le mode conseil est activé Arrêter

BTEC - iShares Nasdaq US Biotechnology UCITS ETF (IE00BYXG2H39)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Sélectionnez tout Réinitialiser tout
 
(%)
IE00BYXG2H39
BTEC ISIN
Fonds négociés en bourse (FNB)
Type de fonds
BlackRock
Fournisseur
8,63 USD
valeur liquidative par action | 11/06/2026
19/10/2017
Date de lancement
Non
Paiement de dividendes
CEOGMS
CFI
BTEC
Ticker
Formed
Status
Equity
Objet d'investissement
Biotech
Secteur
USA
Géographie
Nasdaq Biotechnology Index
Benchmark
0.35 %
Ratio de coût total
927,7 mln USD
Actif total du fonds | 11/06/2026
873,13 mln USD
Volume des actits de classe "actions" | 11/06/2026
Oui
UCITS

Rendement au 18/05/2026, London S.E. (USD)

  • YTD
    0,33 %
  • 1M
    -6,52 %
  • 3M
    -4,83 %
  • 6M
    2,56 %
  • 1Y
    42,2 %
  • 3Y
    39,4 %
  • 5Y
    -
  • 10Y
    -
Au prix de la bourse, avec prise en compte des paiements

Dernières données pour
Ajouter à comparer
de
au
ADD-IN
Add-in Cbonds API
bond data api

Cotations (BTEC)

Explorer la base de données la plus complète

1 000 000

obligations

80 234

actions

167 970

ETF & Funds

80 000

indices

Suivre votre portefeuille de la manière la plus efficace

  • Screener d'obligations
  • liste de surveillance
  • Excel ADD-IN
Obtenir l'accès

Dynamique des prix

Fund profile

The iShares Nasdaq US Biotechnology UCITS ETF seeks to replicate as close as possible the price and yield performance of the NASDAQ Biotechnology Index by investing in a portfolio comprised primarily of biotechnology and pharmaceutical equities listed on the NASDAQ

BTEC profile

The iShares Nasdaq US Biotechnology UCITS ETF is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The BlackRock fund’s base currency is USD and the share class was registered 19.10.2017 with unique ISIN - IE00BYXG2H39. Main exchange is London S.E. (USD) and ticker symbol is BTEC. The total expense ratio is 0.35%. The iShares Nasdaq US Biotechnology UCITS ETF pays dividends 0 time(s) per year.

Structure BTEC au 11/06/2026

Exporter la structure dans Excel
Titre Valeur
AMGEN INC 7,54%
VERTEX PHARMACEUTICALS INC 7,41%
GILEAD SCIENCES INC 6,99%
REGENERON PHARMACEUTICALS INC 5,1%
ALNYLAM PHARMACEUTICALS INC 3,08%
REVOLUTION MEDICINES INC 2,38%
BIOGEN INC 2,36%
ARGENX SE ADR 2,05%
ILLUMINA INC 2,04%
UNITED THERAPEUTICS CORP 1,92%
ROYALTY PHARMA PLC CLASS A 1,9%
INCYTE CORP 1,72%
ROIVANT SCIENCES LTD 1,71%
INSMED INC 1,68%
MODERNA INC 1,58%
VIATRIS INC 1,51%
GUARDANT HEALTH INC 1,38%
NEUROCRINE BIOSCIENCES INC 1,31%
JAZZ PHARMACEUTICALS PLC 1,17%
EXELIXIS INC 1,12%
MEDPACE HOLDINGS INC 1,08%
ASCENDIS PHARMA 1,07%
BRIDGEBIO PHARMA INC 1,05%
AXSOME THERAPEUTICS INC 1,04%
IONIS PHARMACEUTICALS INC 0,98%
MADRIGAL PHARMACEUTICALS INC 0,88%
SANOFI ADR REPRESENTING SA 0,87%
BIOMARIN PHARMACEUTICAL INC 0,86%
ARROWHEAD PHARMACEUTICALS INC 0,84%
BIONTECH SE ADR 0,82%
SUMMIT THERAPEUTICS INC 0,81%
KRYSTAL BIOTECH INC 0,76%
NUVALENT INC CLASS A 0,73%
TEMPUS AI INC CLASS A 0,69%
CYTOKINETICS INC 0,68%
HALOZYME THERAPEUTICS INC 0,67%
BEONE MEDICINES AG 0,67%
ALKERMES 0,6%
IMMUNITYBIO INC 0,59%
PROTAGONIST THERAPEUTICS INC 0,56%
PRAXIS PRECISION MEDICINES INC 0,55%
VAXCYTE INC 0,55%
KYMERA THERAPEUTICS INC 0,55%
IMMUNOVANT INC 0,54%
SPYRE THERAPEUTICS INC 0,51%
PTC THERAPEUTICS INC 0,5%
ABIVAX AMERICAN DEPOSITARY SHARES 0,5%
RHYTHM PHARMACEUTICALS INC 0,48%
MIRUM PHARMACEUTICALS INC 0,48%
COGENT BIOSCIENCES INC 0,43%
AMNEAL PHARMACEUTICALS INC CLASS A 0,41%
LIGAND PHARMACEUTICALS INC 0,41%
CARIS LIFE SCIENCES INC 0,41%
APOGEE THERAPEUTICS INC 0,39%
CG ONCOLOGY INC 0,39%
CRISPR THERAPEUTICS AG 0,39%
INDIVIOR PHARMACEUTICALS INC 0,38%
CENTESSA PHARMACEUTICALS AMERICAN 0,38%
SCHOLAR ROCK HOLDING CORP 0,36%
TWIST BIOSCIENCE CORP 0,36%
TRAVERE THERAPEUTICS INC 0,36%
XENON PHARMACEUTICALS INC 0,35%
ERASCA INC 0,35%
TANGO THERAPEUTICS INC 0,32%
VERACYTE INC 0,3%
ACADIA PHARMACEUTICALS INC 0,29%
EDGEWISE THERAPEUTICS INC 0,29%
CRINETICS PHARMACEUTICALS INC 0,28%
USD CASH 0,28%
NEWAMSTERDAM PHARMA NV 0,28%
10X GENOMICS INC CLASS A 0,28%
STRUCTURE THERAPEUTICS ADR INC 0,27%
DENALI THERAPEUTICS INC 0,27%
ORUKA THERAPEUTICS INC 0,27%
LEGEND BIOTECH ADR REP CORP 0,25%
ARCUTIS BIOTHERAPEUTICS INC 0,25%
BEAM THERAPEUTICS INC 0,24%
DYNE THERAPEUTICS INC 0,24%
ADAPTIVE BIOTECHNOLOGIES CORP 0,23%
TARSUS PHARMACEUTICALS INC 0,22%
ALUMIS INC 0,21%
SUPERNUS PHARMACEUTICALS INC 0,21%
DISC MEDICINE INC 0,21%
RELAY THERAPEUTICS INC 0,21%
IDEAYA BIOSCIENCES INC 0,21%
DEFINIUM THERAPEUTICS INC 0,2%
ENLIVEN THERAPEUTICS INC 0,19%
VERA THERAPEUTICS INC CLASS A 0,19%
KINIKSA PHARMACEUTICALS INTERNATIO 0,19%
GRAIL INC 0,19%
ULTRAGENYX PHARMACEUTICAL INC 0,19%
BIOCRYST PHARMACEUTICALS INC 0,17%
KODIAK SCIENCES INC 0,17%
AURINIA PHARMACEUTICALS INC 0,17%
HARMONY BIOSCIENCES HLDG INC 0,17%
PHARVARIS N V NV 0,16%
ADMA BIOLOGICS INC 0,16%
NOVOCURE LTD 0,16%
VERICEL CORP 0,15%
MINERALYS THERAPEUTICS INC 0,15%
Montrer tout Cacher
Autres - %

Autres actions de ce fonds

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Montrer tout

Autres ETF et fonds de ce fournisseur

ETF et fonds similaires

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    Valeur nette d'actifs
    {{ item.expense_ratio }}
    Ratio de coût total
Vous devez vous inscrire pour y accéder.